Literature DB >> 17670726

In vitro cardiomyogenic differentiation of adult human bone marrow mesenchymal stem cells. The role of 5-azacytidine.

Polychronis Antonitsis1, Elisavet Ioannidou-Papagiannaki, Aikaterini Kaidoglou, Christos Papakonstantinou.   

Abstract

The aim of this study is to investigate the ability of adult human bone marrow mesenchymal stem cells to differentiate towards a cardiomyogenic phenotype in vitro. Bone marrow samples have been aspirated from 30 patients undergoing open heart surgery. Mesenchymal stem cells were isolated and cultured in enriched medium. Second passaged cells were treated with 10 microM 5-azacytidine for 24 h. Selected surface antigens were analyzed by flow cytometry. Morphologic characteristics were analyzed by confocal and electron microscopy. Expression of cytoskeletal protein vimentin and muscle specific myosin heavy chain were analyzed by immunohistochemistry. Expression of alpha-cardiac actin, beta-myosin heavy chain and cardiac troponin-T was detected by reverse transcriptase polymerase chain reaction. Mesenchymal stem cells were spindle-shaped with irregular processes. Cells treated with 5-azacytidine have assumed a stick-like morphology. They were connecting with adjoining cells forming myotube-like structures. Numerous myofilaments were detected in induced cells running in a parallel fashion without forming sarcomeres that were immunohistochemically positive for myosin heavy chain and vimentin. The mRNAs of alpha-cardiac actin, beta-myosin heavy chain and troponin-T were expressed in both induced and uninduced cells. These results indicate that adult human bone marrow mesenchymal stem cells can differentiate towards a cardiomyogenic lineage in vitro.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17670726     DOI: 10.1510/icvts.2007.157875

Source DB:  PubMed          Journal:  Interact Cardiovasc Thorac Surg        ISSN: 1569-9285


  43 in total

1.  ADSCs differentiated into cardiomyocytes in cardiac microenvironment.

Authors:  Yanxia Zhu; Tianqing Liu; Kedong Song; Ruiming Ning; Xuehu Ma; Zhanfeng Cui
Journal:  Mol Cell Biochem       Date:  2008-12-24       Impact factor: 3.396

Review 2.  Mesenchymal stem cells for treatment of myocardial infarction.

Authors:  Il-Kwon Ko; Byung-Soo Kim
Journal:  Int J Stem Cells       Date:  2008-11       Impact factor: 2.500

3.  Cardiomyocyte marker expression in a human lymphocyte cell line using mouse cardiomyocyte extract.

Authors:  Zahra Vojdani; Sima Tavakolinejad; Tahereh Talaei-Khozani; Tahereh Esmaeilpour; Manuchehr Rasooli
Journal:  Hum Cell       Date:  2011-02-18       Impact factor: 4.174

Review 4.  Molecular advances in reporter genes: the need to witness the function of stem cells in failing heart in vivo.

Authors:  Silvia Agostini; Fabio A Recchia; Vincenzo Lionetti
Journal:  Stem Cell Rev Rep       Date:  2012-06       Impact factor: 5.739

5.  Enhanced cardiomyogenic induction of mouse pluripotent cells by cyclic mechanical stretch.

Authors:  Akankshya Shradhanjali; Brandon D Riehl; Jeong Soon Lee; Ligyeom Ha; Jung Yul Lim
Journal:  Biochem Biophys Res Commun       Date:  2017-05-17       Impact factor: 3.575

6.  CD73+ adipose-derived mesenchymal stem cells possess higher potential to differentiate into cardiomyocytes in vitro.

Authors:  Qiong Li; Li-Jie Qi; Zhi-Kun Guo; He Li; Hong-Bo Zuo; Na-Na Li
Journal:  J Mol Histol       Date:  2013-03-03       Impact factor: 2.611

7.  Inflammation in myocardial injury: mesenchymal stem cells as potential immunomodulators.

Authors:  Weiang Yan; Ejlal Abu-El-Rub; Sekaran Saravanan; Lorrie A Kirshenbaum; Rakesh C Arora; Sanjiv Dhingra
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-05-24       Impact factor: 4.733

8.  Ischemic cardiac tissue conditioned media induced differentiation of human mesenchymal stem cells into early stage cardiomyocytes.

Authors:  Balasundari Ramesh; Dillip Kumar Bishi; Suneel Rallapalli; Sarasabarathi Arumugam; Kotturathu Mammen Cherian; Soma Guhathakurta
Journal:  Cytotechnology       Date:  2012-03-07       Impact factor: 2.058

9.  Icariin stimulates the proliferation of rat bone mesenchymal stem cells via ERK and p38 MAPK signaling.

Authors:  Shuyan Qin; Wei Zhou; Shaoying Liu; Puxiang Chen; Hongjin Wu
Journal:  Int J Clin Exp Med       Date:  2015-05-15

10.  Enhanced cardiomyogenic differentiation of P19 embryonal carcinoma stem cells.

Authors:  Jihyun Yang; Seok-Jin Ko; Beom-Suk Kim; Hyun-Seo Kim; Sangheon Park; Doran Hong; Soon-Woong Hong; Ji-Hyun Choi; Chi-Yeon Park; Seung-Cheol Choi; Sun-Jun Hong; Do-Sun Lim
Journal:  Korean Circ J       Date:  2009-05-28       Impact factor: 3.243

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.